SCHEMBL25657017

SCHEMBL25657017

Clc1ccccc1-c1cccc2c1C1(c3c-2ccc2ccccc32)C2CC3CC(C2)CC1C3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
CYP2A6 P11509 2/20 0.39
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 2/20 0.36
TP53 P04637 2/20 0.35
SLC6A3 Q01959 1/20 0.33
HSD11B1 P28845 1/20 0.33
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
MAPT P10636 2/20 0.32
ABCB1 P08183 1/20 0.31
CXCR3 P49682 1/20 0.31
RAB9A P51151 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
KMT2A Q03164 1/20 0.30
NPC1 O15118 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316483 0.93 CYP2A6 (0.40) CYP1A2CYP2A6CYP1A1CYP1B1TP53
SCHEMBL24316387 0.85 CYP1A2 (0.38) CYP1A2CYP2A6CYP1A1CYP1B1TP53
SCHEMBL25657026 0.83 PDK2 (0.34) CYP1A2CYP2A6CYP1A1CYP1B1TP53
SCHEMBL25657018 0.82 DHFR (0.34) CYP1A2MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL24317038 0.82 MEN1 (0.32) MAPTRAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24316490 0.82 CYP2A6 (0.37) CYP1A2CYP2A6TP53SLC6A3HSD11B1
SCHEMBL25618473 0.80 HSD11B1 (0.35) HSD11B1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL25035904 0.80 EGFR (0.35) CYP1A2CYP1A1CYP1B1TP53MAPT
SCHEMBL25625946 0.80 CA12 (0.35) CYP1A2MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL25038236 0.79 SLC6A3 (0.37) CYP1A2CYP2A6CYP1A1CYP1B1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146776-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-05-11 US disclosed
US-20230146776-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146776-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, EED, ACHE CYP1A2 1596/4885CYP2A6 3485/4885CYP1A1 1376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.